MedPath

THE UNIVERSITY OF HONG KONG

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Interventions
First Posted Date
2008-11-24
Last Posted Date
2017-01-10
Lead Sponsor
The University of Hong Kong
Target Recruit Count
60
Registration Number
NCT00796679
Locations
🇭🇰

University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong

🇭🇰

Queen Mary Hospital, Hong Kong, Hong Kong

Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children

Not Applicable
Completed
Conditions
Influenza Virus Infection
Interventions
Biological: Inactivated influenza vaccine
Biological: Saline
First Posted Date
2008-11-17
Last Posted Date
2014-12-30
Lead Sponsor
The University of Hong Kong
Target Recruit Count
2800
Registration Number
NCT00792051
Locations
🇨🇳

The University of Hong Kong, Hong Kong, China

Safety of Coronectomy vs Excision of Wisdom Teeth

Not Applicable
Completed
Conditions
Pain
Infection
Alveolar Nerve Injury
Interventions
Procedure: Coronectomy
Procedure: Total Excision
First Posted Date
2008-09-15
Last Posted Date
2008-12-08
Lead Sponsor
The University of Hong Kong
Target Recruit Count
349
Registration Number
NCT00752284
Locations
🇨🇳

Prince Philip Dental Hospital, Hong Kong, China

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma

Phase 2
Conditions
Advanced Hepatocellular Carcinoma
Metastatic Hepatocellular Carcinoma
Interventions
First Posted Date
2008-09-15
Last Posted Date
2008-09-15
Lead Sponsor
The University of Hong Kong
Target Recruit Count
52
Registration Number
NCT00752063
Locations
🇨🇳

Queen Mary Hospital, Hong Kong, China

Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients

Phase 4
Completed
Conditions
End-stage Renal Disease
Interventions
Drug: placebo comparator
First Posted Date
2008-09-03
Last Posted Date
2021-10-08
Lead Sponsor
The University of Hong Kong
Target Recruit Count
160
Registration Number
NCT00745225
Locations
🇭🇰

Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong

Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients

Not Applicable
Completed
Conditions
Endstage Renal Disease
Diabetes
Interventions
Drug: Placebo comparator
First Posted Date
2008-09-03
Last Posted Date
2017-01-10
Lead Sponsor
The University of Hong Kong
Target Recruit Count
22
Registration Number
NCT00745914
Locations
🇭🇰

Queen Mary Hospital and Tung Wah Hospital, Hong Kong, Hong Kong

🇭🇰

Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong

Parathyroidectomy in Endstage Renal Disease

Not Applicable
Completed
Conditions
Endstage Renal Disease
Interventions
Procedure: parathyroidectomy
First Posted Date
2008-09-03
Last Posted Date
2020-08-05
Lead Sponsor
The University of Hong Kong
Target Recruit Count
122
Registration Number
NCT00745719
Locations
🇭🇰

Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong

Sevelamer Hydrochloride in Peritoneal Dialysis Patients

Not Applicable
Completed
Conditions
Endstage Renal Disease
Interventions
First Posted Date
2008-09-03
Last Posted Date
2020-06-18
Lead Sponsor
The University of Hong Kong
Target Recruit Count
60
Registration Number
NCT00745589
Locations
🇭🇰

Queen Mary Hospital, Tung Wah Hospital, Hong Kong, Hong Kong

Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury

Phase 1
Completed
Conditions
Spinal Cord Injuries
First Posted Date
2007-02-05
Last Posted Date
2012-01-16
Lead Sponsor
The University of Hong Kong
Target Recruit Count
20
Registration Number
NCT00431171
Locations
🇨🇳

MacLehose Medical Rehabilitation Centre, Pokfulam, Hong Kong SAR, China

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Phase 2
Conditions
Nasopharyngeal Neoplasms
Interventions
First Posted Date
2006-08-15
Last Posted Date
2010-07-28
Lead Sponsor
The University of Hong Kong
Target Recruit Count
42
Registration Number
NCT00363831
Locations
🇭🇰

Sanofi-aventis, Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath